01-07-2012 17:53 A VERY BAD EXPERIENCE WITH MEDICATION AND CONDITIONS AT MOUNT SINAI HOSPITAL IN NYC. 2010..

See the rest here:
MOUNT SINAI HOSPITAL 2010 NEUROLOGY UNIT - Video

Here is an excerpt from a recent review article in the official AFP journal American Family Physician:

Acute low back pain is one of the most common reasons for adults to see a physician. Most patients recover quickly with minimal treatment.

"Red flags"

Serious "red flags" include:

- significant trauma related to age (i.e., injury related to a fall from a height or motor vehicle crash in a young patient, or from a minor fall or heavy lifting in a patient with osteoporosis or possible osteoporosis)
- major or progressive motor or sensory deficit
- new-onset bowel or bladder incontinence or urinary retention
- loss of anal sphincter tone
- saddle anesthesia
- history of cancer metastatic to bone
- suspected spinal infection

Diagnosis

Without signs of serious pathology, imaging and laboratory testing often are not required.

Treatment

Patient education, nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and muscle relaxants are beneficial.

Bed rest should be avoided, if possible.

Exercises directed by a physical therapist, such as the McKenzie method and spine stabilization exercises, may decrease recurrent pain.

Spinal manipulation and chiropractic techniques are no more effective than established medical treatments.

No substantial benefit has been shown with:

- oral steroids
- acupuncture
- massage
- traction
- lumbar supports
- regular exercise programs

References:

Diagnosis and treatment of acute low back pain. Casazza BA. Am Fam Physician. 2012 Feb 15;85(4):343-50.

Image source: Different regions (curvatures) of the vertebral column, Wikipedia, public domain.

Source:
http://feeds.feedburner.com/CasesBlog

Here is an excerpt from a review article in the official AAFP journal American Family Physician:

Causes of genital ulcers

Herpes simplex virus (HSV) infection and syphilis are the most common causes of genital ulcers in the U.S.

Other infectious causes include:

- chancroid
- lymphogranuloma venereum (LGV)
- granuloma inguinale (donovanosis)
- secondary bacterial infections
- fungi

Noninfectious etiologies of genital ulcers include:

- sexual trauma
- psoriasis
- Behçet syndrome
- fixed drug eruptions

CDC Streaming Health | This video, produced by Be Smart. Be Well., raises awareness of Sexually Transmitted Diseases (STDs): 1) What are they? 2) Why they matter? and, 3) What can I do about them? Footage courtesy of Be Smart. Be Well. http://www.besmartbewell.com, featuring CDC's Dr. John Douglas, Division of Sexually Transmitted Disease Prevention.

Diagnosis

The following tests should be considered in all patients:

- serologic tests for syphilis and darkfield microscopy or direct fluorescent antibody testing for Treponema pallidum
- culture or polymerase chain reaction test for herpes simplex virus (HSV)
- culture for Haemophilus ducreyi in settings with a high prevalence of chancroid

No pathogen is identified in up to 25% of patients with genital ulcers.

Treatment

The first episode of herpes simplex virus infection is usually treated with 7-10 days of oral acyclovir (5 days for recurrent episodes). Famciclovir and valacyclovir are alternative therapies.

One dose of intramuscular penicillin G benzathine is recommended to treat genital ulcers caused by primary syphilis.

Treatment options for chancroid include a single dose of intramuscular ceftriaxone or oral azithromycin, ciprofloxacin, or erythromycin.

Lymphogranuloma venereum and donovanosis are treated with 21 days of oral doxycycline.

Treatment of noninfectious causes of genital ulcers varies by etiology, of course. Topical wound care for ulcers caused by sexual trauma. Subcutaneous pegylated interferon alfa-2a is considered for ulcers caused by Behçet syndrome.

References:

Diagnosis and management of genital ulcers. Roett MA, Mayor MT, Uduhiri KA. Am Fam Physician. 2012 Feb 1;85(3):254-62.

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/bwd77m/republic_of_korea) has announced the addition of GlobalData's new report "Republic of Korea Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Republic of Korea Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Republic of Korea Neurology Devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

Read the original:
Research and Markets: Republic of Korea Neurology Devices Market Outlook to 2018 - Interventional Neurology ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/bz7thk/netherlands_neurol) has announced the addition of GlobalData's new report "Netherlands Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Netherlands Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Netherlands Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Netherlands Neurology Devices market.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

Go here to read the rest:
Research and Markets: Netherlands Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

A new neurology residency program has been approved for Palmetto Health and the USC School of Medicine, a move designed to meet a severe need in the state.

South Carolina has one of the highest stroke rates of any state, ranking in the top 10 for stroke deaths per capita. Every hospital, large and small, has to deal with stroke patients. But many small hospitals dont have stroke neurologists, according to Dr. Souvik Sen, who will direct the new residency program.

We do have a shortage of neurologists, Sen said. Stroke neurologists are very specialized, and every hospital needs at least one.

Video from around the world

The new program, recently approved by the national Accreditation Council for Graduate Medical Education, should help reduce the shortage, though it will take a few years. The program will accept a class of three residents per year, and the training takes four years, Sen said.

The costs of the program are being shared by Palmetto Health, the Veterans Administration and the USC School of Medicine. Residents will do clinical work at both Palmetto Health and the Dorn VA Hospital under a team of 12 physician instructors. The first class will begin in July 2013, Sen said.

The state already has one neurology residency program at the Medical University of South Carolina in Charleston. MUSCs program traditionally has a class of four or five new residents each year.

The number of medical school students in the state has increased slightly in recent years and will see a big jump this year with the addition of a four-year program starting at the University of South Carolina School of Medicine in Greenville. The Greenville schools first class will have 50 students, and school leaders hope to grow to 100 new students each year. The USC School of Medicine in Columbia enrolls about 100 each year, and MUSC takes in a class of about 170.

But the number of residency programs, which provide clinical training after med school, hasnt increased in the state much in the past few years. That means more medical students from state schools have to go outside the state for training, and those doctors are less likely to return to the state, health experts say.

Palmetto Health and USC School of Medicine already have residency programs in dentistry, emergency medicine, family medicine, internal medicine, pediatrics, obstetrics and gynecology, orthopedic surgery, general psychiatry, child and adolescent psychiatry and surgery.

See the article here:
Neurology residency program to meet stroke treatment needs

Here are 3 infographic templates for Google Drive by Google:

Infographics Toolbox By Google - Illustrate your data with your own custom graphs, charts, maps and more. Draw your own pie charts and bar charts with this template. Edit the colors of the map of the United States. Create an infographic of male and female symbols to use for counting data (including one-half male and female symbols). http://goo.gl/R0Cjh

United States Data Map By Google - This map of the United States is shaded based on state-by-state data. Just click on each state and set a custom color based on the information that you want to display. Then adjust the key at the bottom of the drawing to describe your custom data. The default data displayed is the population density from the year 2000 census. Notes: - States with multiple unconnected parts have been created as grouped shapes (eg. Hawaii, Michigan). - Washington DC starts as a grouped shape with Maryland. - Map can be changed to be displayed at any size. Using the same border for all states (eg. 1px white) is recommended. http://goo.gl/KjM3H

Map of the United States (Multi-colored) By Google - This map of the United States is colored with 5 standard colors to distinguish each state outline. Each set of same-colored states is a grouped shape, just click a state and change the color to choose custom map colors for all those states. A gray shadow of the states outlines adds a lightweight 3D effect. http://goo.gl/p58VS

Related reading:

How to Get Started With Infographics | PCWorld Business Center http://goo.gl/ViWk2

How To Create Your Own Infographics: Step By Step Guide and Tips - TechTheBest.com  http://goo.gl/pT2mH

Source:
http://feeds.feedburner.com/CasesBlog

From Mayo Clinic YouTube channel: Imagine what life would be like if you lost your hearing. No music, no sounds of nature, no listening to the voices of your loved ones. But some people with profound hearing loss do have options. Cochlear implants, in the right patients, offer the chance to hear again.

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/w46qxh/hungary_neurology) has announced the addition of Global Markets Direct's new report "Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018" to their offering.

Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018, a new report by Global Markets Direct, provides key market data on the Hungary Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Hungary Neurology Devices market.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

See the rest here:
Research and Markets: Hungary Neurology Devices Investment Opportunities, Analysis and Forecasts to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jsk2sx/denmark_neurology) has announced the addition of GlobalData's new report "Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Denmark Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Scope

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products .

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Denmark Neurology Devicesmarket.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

See original here:
Research and Markets: Denmark Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/vs9lrf/belgium_neurology) has announced the addition of GlobalData's new report "Belgium Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Belgium Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Belgium Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Belgium Neurology Devices market.

Companies Mentioned:

See original here:
Research and Markets: Belgium Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/q5ctlz/france_neurology_d) has announced the addition of GlobalData's new report "France Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

This new report provides key market data on the France Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the France Neurology Devices market.

- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Accuray Incorporated, Stryker Corporation, Cadwell Laboratories, Inc., B. Braun Melsungen AG and others.

Read more:
Research and Markets: France Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/nlp2hj/argentina_neurolog) has announced the addition of GlobalData's new report "Argentina Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report provides key market data on the Argentina Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Neurology Devices market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within six market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the six market categories.

- Global corporate-level profiles of key companies operating within the Argentina Neurology Devices market.

- Key players covered include Medtronic, Inc., Nihon Kohden Corporation, St. Jude Medical, Inc., Stryker Corporation, Cadwell Laboratories, Inc., DePuy, Inc. and others.

Original post:
Research and Markets: Argentina Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

The former president George H.W. Bush wrote a poem for his grandkids:

"So I can add to the report on getting older. 

Who knows, maybe they’ll come out with a new drug that makes legs bend easier,
Joints hurt less, drives go further, memory come roaring back,
And all fears about falling off fishing rocks go away. 

Remember the old song: I’ll be there ready when you are.
Well I’ll be there ready when you are
There’s so much excitement ahead, so many grandkids to watch grow.
If you need me I’m here."

By the way, the 88-year-old former president said he was not done skydiving. His goal: to jump again when he is 90.

References:

'If you need me I'll be there': George HW Bush moved to tears during interview with granddaughter Jenna about his family and growing old | Daily Mail Online http://goo.gl/noCt0

Source:
http://feeds.feedburner.com/CasesBlog

The Meibomian glands (or tarsal glands) are sebaceous glands at the rim of the eyelids, responsible for the supply of meibum, an oily substance that prevents evaporation of the eye's tear film. They prevent tear spillage onto the cheek, trapping tears between the oiled edge and eyeball, and make the closed lids airtight. There are approximately 50 glands on the upper eyelids and 25 glands on the lower eyelids. The glands are named after Heinrich Meibom (1638–1700), a German physician (source: Wikipedia).

The LipiFlow Thermal Pulsation System uses heat and pressure to open blockages of the eyelid (Meibomian) glands. The treatment was approved by the FDA in 2011. Here is more information: http://lipiflow.com

Here is a Mayo Clinic video about the procedure:

Source:
http://feeds.feedburner.com/CasesBlog

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/759qr2/australia_neurolog) has announced the addition of GlobalData's new report "Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Australia Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 Neurology Devices In Australia

4 CSF Management In Australia

5 Interventional Neurology In Australia

6 Neurological Diagnostic Equipment In Australia

See more here:
Research and Markets: Australia Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/dsmzkg/austria_neurology) has announced the addition of GlobalData's new report "Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, "Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" provides key market data on the Austria Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories - CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Neurosurgical Products. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 Neurology Devices In Austria

4 CSF Management In Austria

5 Interventional Neurology In Austria

6 Neurological Diagnostic Equipment In Austria

Here is the original post:
Research and Markets: Austria Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...

15-06-2012 17:27 On the heels of the unfortunate San Gabriel hit-and-run incident involving US Commerce Secratary, John Bryson, Huntington Hospital's own Dr. William Sutherling discusses the risks of seizure disorders,and the need discover the source of the neurological event.

Read the original here:
Neurologist, Dr. William Sutherling Discusses Seizure Disorders (6/11/2012) - Video

Newswise PHILADELPHIA Frances E. Jensen, MD, has been named Chair of the Department of Neurology in the Perelman School of Medicine at the University of Pennsylvania. She comes to Penn Medicine from Boston, where she is currently Professor of Neurology at Harvard Medical School and a senior neurologist at both Brigham and Womens Hospital and Childrens Hospital, Boston. Starting August 13, Jensen will become the 11th chair to lead Penns Department of Neurology, the oldest neurology department in the United States, founded by Dr. Horatio Wood in 1871.

I am confident that Dr. Jensen, with her range of research strengths, teaching skills, and clinical dedication, is the perfect person to lead the Department into the future and help to shape our many initiatives in neuroscience, said J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System. Dr. Jensen is a dedicated and inspiring teacher and mentor, and is highly regarded for her translational research and studies of the age-specific mechanisms of diseases of the brain across the lifespan.

Dr. Jensens research has focused on investigating pathophysiological mechanisms of epilepsy as well as secondary effects on synaptic plasticity. She has been exploring age-dependent differences in such mechanisms, with special attention to the interactions among brain development, excitotoxic brain injury, epilepsy, and cognition.

Most recently, supported by a five-year Directors Pioneer Award from the (NIH), Dr. Jensen has been investigating connections between epilepsy and autism, examining how seizures in early life alter neuronal networks in the developing brain to cause cognitive disorders such as learning deficits, neuropsychiatric symptoms, and autism. As she told Nature Medicine last year, We are finding connections between previously assumed unrelated disorders that we could never have imagined.

Dr. Jensen is the sponsor of an FDA-approved Investigational New Drug (IND) for a continuing multi-center clinical trial of a novel therapy for neonatal seizures, based on basic research in her laboratory.

After graduating cum laude from Smith College with an A.B. degree in neuropsychology, Dr. Jensen received her medical degree from Cornell University Medical College. She took her residency in internal medicine at Brigham and Womens Hospital and was Chief Resident in neurology at The Harvard Longwood Neurology Training Program. Dr. Jensen was also a clinical fellow and an instructor in neurology at Harvard Medical School. She became an Assistant Professor of Neurology in 1992, Associate Professor in 1998, and Professor in 2007.

She serves as Director of Translational Neuroscience at Childrens Hospital and is a senior neurologist at both Brigham and Womens Hospital and Childrens Hospital. She is also active in education and mentoring programs related to translational medicine at the Harvard Clinical and Translational Science Center.

Dr. Jensen is the author of more than 100 manuscripts. She is a Fellow of the American College of Physicians, a member of the editorial board of Annals of Neurology, and a reviewing editor for the Journal of Neuroscience. In addition to the Directors Pioneer Award, NIH has awarded her a Physician Scientist Award and a First Independent Research Support and Transition (FIRST) Award. Dr. Jensen is a Council Member of the Society for Neuroscience and is currently serving as President of the American Epilepsy Society. She also served as Chair of the American Epilepsy Society Annual Meeting Committee and Council on Education and oversaw the successful process of accreditation by the ACCME (Accreditation Council for Continuing Medical Education). In 2008, she received the American Epilepsy Society Research Recognition Award for Basic Science. She has served on multiple review and council positions in private foundations and National Institutes of Health. Dr. Jensen has also been active in community service and media: she has been a visiting teacher at local schools and has been an expert commentator on such programs as The Today Show, 60 Minutes, National Public Radios Morning Edition, and Good Morning America.

# # #

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

See original here:
Frances E. Jensen, MD, Named Chair of the Department of Neurology

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pzllkj/italy_neurology_de) has announced the addition of GlobalData's new report "Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others" to their offering.

GlobalData's new report, Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others provides key market data on the Italy Neurology Devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories:

- CSF Management

- Interventional Neurology

- Neurological Diagnostic Equipment

- Neurostimulation Devices

- Neurosurgical Products and Radiosurgery

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

View original post here:
Research and Markets: Italy Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological ...